These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2201154)

  • 1. [The reactogenicity and immunological efficacy of a Klebsiella vaccine in donors].
    Kurbatova EA; Egorova NB; Dubova VG; Davatdarova GM; Lipats AA; Gervazieva VB; Kaverina KG
    Zh Mikrobiol Epidemiol Immunobiol; 1990 May; (5):53-6. PubMed ID: 2201154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The immunological response in volunteer donors immunized with a Pseudomonas vaccine].
    Makarenko TA; Balaian SS; Sergienko AI; Stanislavskiĭ ES; Edvabnaia LS; Abramova IA; Krokhina MA; Rusanov VM
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Nov; (11):39-41. PubMed ID: 1811387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isolation and study of the properties of a polyvalent corpuscular Pseudomonas aeruginosa vaccine. An evaluation of the biological properties of a polyvalent corpuscular Pseudomonas aeruginosa vaccine].
    Ttitova TI; Grigor'ev NI; Antsiferova NG; Radkevich SA; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jul; (7):14-8. PubMed ID: 3931392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The antigen-specific activity of a multicomponent vaccine administered orally and subcutaneously].
    Mansurova NL; Chuprinina RP; Egorova NB; Kuz'mina LA; Skorikova IG; Kaverina KG
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):37-9. PubMed ID: 7539974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of a hydroxylamine Klebsiella vaccine on the rate of elimination of the causative agent and on indices of humoral immunity].
    Kurbatova EA; Lazareva ES; Gladus MA
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Sep; (9):75-9. PubMed ID: 3061265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered to victims of acute trauma.
    Campbell WN; Hendrix E; Cryz S; Cross AS
    Clin Infect Dis; 1996 Jul; 23(1):179-81. PubMed ID: 8816151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The antigenic activity of vaccines made from opportunistic microorganisms in an experiment to immunize animals by oral and combined methods].
    Efremova VN; Poliachenko VM; Kaverina KG
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Feb; (2):40-3. PubMed ID: 1441812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The evaluation of the reactogenicity and immunogenic activity of a new concentrated inactivated leptospirosis vaccine].
    Ikoev VN; Gorbunov MA; Vachaev BF; Iagovkin EA; Kondratenko VF; Anan'ina IuV; Ansimova TI; Kostina NI; Iur'eva IL; Nikitin MG
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (4):39-43. PubMed ID: 10852048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of Klebsiella pneumoniae K1 capsular polysaccharide vaccine in humans.
    Cryz SJ; Fürer E; Germanier R
    J Infect Dis; 1985 Apr; 151(4):665-71. PubMed ID: 3882856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Naso-subcutaneous application of the polycomponent vaccine VP-4 for the treatment of patients with bronchial asthma and chronic obstructive bronchitis].
    Antonova LP; Markova TP; Kurbatova EA
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (6):36-40. PubMed ID: 15636137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The reactogenicity and antigenic activity of a meningococcal group B vaccine made from a natural complex of the specific polysaccharide and outer membrane proteins].
    Basnak'ian IA; Alliluev AP; Kuvakina VI; Levina LA; Krasnoproshina LI; Kotel'nikova OV; Karabak VI; Mordvitskiĭ AM; Borovkova VM; Aleksakhina NN
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Dec; (12):50-5. PubMed ID: 2129147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneously.
    Edelman R; Taylor DN; Wasserman SS; McClain JB; Cross AS; Sadoff JC; Que JU; Cryz SJ
    Vaccine; 1994 Nov; 12(14):1288-94. PubMed ID: 7856293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of antigens as vaccine candidates against Klebsiella pneumoniae.
    Lundberg U; Senn BM; Schüler W; Meinke A; Hanner M
    Hum Vaccin Immunother; 2013 Mar; 9(3):497-505. PubMed ID: 23250007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of a study of the safety, reactogenicity and immunologic effectiveness of pyoimmunogen in the immunization of volunteer donors].
    Krokhina MA; Grishina IA; Arkhipova NA; Zarubina EK; Edvabnaia LS
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):95-8. PubMed ID: 7331614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The specific activity of a multicomponent vaccine made from the antigens of opportunistic microorganisms].
    Mansurova NL; Egorova NB; Kaverina KG; Poliachenko VM; Lobova EA
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Apr; (4):39-41. PubMed ID: 1882605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protective effect of the aerosol immunization of mice with the polycomponent vaccine Immunovac VP-4 after the challenge of the animals with Klebsiella pneumoniae virulent strain].
    Solov'ev KG; Kurbatova EA; Egorova NB; Uspenskaia SN; Tret'iakova AV; Varfolomeev AN; Gruber IM; Efremova VN; Akhmatova NK; Diadizhshev NR; Akhmatova IB; Diadishchev NR; Semenova IB; Cherkasova LS; Semenov BF; Borovik RV
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (1):20-5. PubMed ID: 16532635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dynamic anti-Proteus immunity in plasma donors during plasmapheresis].
    Nazarchuk LV; Fedorovskaia EA
    Vrach Delo; 1991 May; (5):35-8. PubMed ID: 1866911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the reactogenic and immunogenic properties of meningococcal vaccines].
    Demina AA; Parunina TM; Deviatkin NP; Martynov IuV; Koroleva IS
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Nov; (11):88-92. PubMed ID: 6441402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with the outer membrane proteins OmpK17 and OmpK36 elicits protection against Klebsiella pneumoniae in the murine infection model.
    Hussein KE; Bahey-El-Din M; Sheweita SA
    Microb Pathog; 2018 Jun; 119():12-18. PubMed ID: 29626658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of the reactogenicity and immunogenicity of various doses of a chemical polysaccharide meningococcal vaccine administered by syringe and jet injector].
    Pavlova LI; Nefedova LA; Nikitiuk NM; Chernysheva TF; Alliluev AP
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Nov; (11):58-64. PubMed ID: 6419514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.